Related Experiment Videos
Histological studies on developing chick embryos treated with aminoguanidine sulfate
The Journal of Toxicological Sciences
|May 1, 1985
Summary
Aminoguanidine sulfate (AGS) causes significant liver, gallbladder, and spleen abnormalities in developing chick embryos. AGS exposure leads to developmental delays and organ damage, highlighting its teratogenic potential.
Area of Science:
- Developmental Biology
- Toxicology
- Teratology
Background:
- Aminoguanidine sulfate (AGS) is a chemical compound with known biological effects.
- Understanding the impact of chemical exposure on embryonic development is crucial for assessing potential risks.
Purpose of the Study:
- To investigate the teratogenic effects of aminoguanidine sulfate (AGS) on embryonic development.
- To identify specific organ abnormalities induced by AGS exposure during incubation.
Main Methods:
- Fertile eggs were administered 10 or 20 mg/egg of AGS into the albumen on day 5 of incubation.
- Embryos were examined macroscopically and histopathologically to assess developmental changes.
- Mitotic activity and cellular changes in target organs were analyzed.
Main Results:
- Significant abnormalities were observed in the liver, gallbladder, and spleen of AGS-treated embryos.
- Early changes included increased mitotic cells and metaphase ratios in the liver, followed by weight decrease, developmental retardation, fatty degeneration, necrosis, and increased connective tissue.
- Gallbladder abnormalities (aplasia, hypoplasia) and spleen enlargement with fatty degeneration were frequent findings.
Conclusions:
- Aminoguanidine sulfate (AGS) exposure during embryonic development induces severe, dose-dependent abnormalities in the liver, gallbladder, and spleen.
- AGS demonstrates significant teratogenic potential, impacting organogenesis and overall embryonic development.